How to Read Your CCCA Scalp Biopsy Report: Key Terms

When you are evaluated for Central Centrifugal Cicatricial Alopecia (CCCA), your dermatologist may perform a scalp biopsy. A biopsy gives a microscopic snapshot of your hair follicles to help support a diagnosis ^[1]. Reading your own pathology report can be intimidating because it is filled with complex terminology.

However, the terms on your report—like PDIRS, loss of sebaceous glands, and fibrotic tracts—describe the structural health of the sampled hair follicles ^[1][2]. Understanding these terms can help you have a more informed conversation with your care team.

Note: A biopsy is only one piece of the puzzle. Dermatologists combine these microscopic clues with a visual exam, your symptoms, and clinical history to confirm a diagnosis.

Decoding Key Biopsy Terms

PDIRS (Premature Desquamation of the Inner Root Sheath)

The inner root sheath is a protective layer that surrounds and supports your hair shaft as it grows. Desquamation means peeling or shedding. PDIRS indicates that this protective inner layer is breaking down or shedding much earlier than it normally should ^[1].

What it means: When identified by a dermatopathologist, especially in hair follicles that are not currently inflamed, PDIRS is a highly characteristic clue for CCCA ^[1]. While it is not a standalone guarantee of the disease—since similar features can sometimes appear in other conditions—it strongly supports a CCCA diagnosis when interpreted alongside your clinical exam ^[1].

Loss of Sebaceous (Oil) Glands

Healthy hair follicles generally have a sebaceous gland attached, which produces sebum (oil) to keep the hair and scalp moisturized.

What it means: “Loss of sebaceous glands” means these glands are not visible in the sampled tissue ^[3]. Because a biopsy is a very small sample, a missing gland could sometimes just be a result of how the tissue was sliced. However, in the context of hair loss, a true reduction or loss of sebaceous glands is an important sign of structural follicular injury ^[3]. It is often one of the earlier changes seen when a follicle is damaged by a scarring process like CCCA.

Fibrotic Tracts and Concentric Fibroplasia

Fibrosis is the medical term for scarring.

• Concentric fibroplasia: This means that scar tissue has formed in layered, ring-like bands around the hair follicle ^[2]. It essentially squeezes, remodels, and damages the follicle structure ^[2].
• Fibrotic tracts (or fibrous streamers): This refers to areas where hair follicles have been completely replaced by bands of scar tissue ^[2].

What it means: These terms indicate that permanent scarring is occurring or has already occurred in the sampled area ^[3][2]. In the specific spots where fibrotic tracts have completely replaced a follicle, that specific follicle is destroyed and cannot grow new hair. However, this does not mean the entire area is hopeless; treatment focuses on preserving the remaining follicles that have not yet been fully destroyed by fibrosis.

Inflammation vs. Scarring

Your biopsy report will likely mention the presence or absence of inflammation, often described as a lymphocytic infiltrate (a collection of immune cells called lymphocytes) ^[3]. CCCA is an inflammatory scarring condition, meaning an inflammatory response is associated with the damage to the follicles ^[3].

The primary goal of CCCA treatment is to stop this inflammation before it causes more permanent fibrotic tracts ^[3].

• If your report shows active inflammation (lymphocytic infiltrates) alongside PDIRS and gland loss, it suggests the disease process is active in that specific area.
• If your report shows severe scarring with little to no inflammation, it might suggest the disease in that tiny sample has reached a late, scarred stage. However, inflammation can be patchy or temporarily suppressed by treatments, so a lack of inflammation on a biopsy does not guarantee the disease is completely stable.

What a Biopsy Cannot Tell You

• It cannot map your entire scalp: A biopsy samples a spot smaller than a pencil eraser. One area might be heavily scarred, while a few inches away, the follicles might just be showing early signs of injury.
• It cannot precisely predict regrowth: It shows what has been damaged, but clinical follow-up is needed to see how well you respond to treatment.
• It cannot prove the disease has stopped: Because inflammation is patchy, your doctor will rely on follow-up photos, symptom tracking, and physical exams—not just the biopsy—to determine if the disease is still progressing.